BVXV   $1.35  0.74% Market Closed

Biondvax Pharmaceuticals Ltd
Total Cash 7.51M
totalCashPerShare 2.065
EBITDA -10.40M
Total Debt 24.61M
quickRatio 3.976
currentRatio 4.115
Total Revenue
debtToEquity
Revenue/Share
ROA -0.30893
ROE
grossProfits
freeCashflow -9.54M
operatingCashflow -8.43M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 21.94M
forwardPE
floatShares 2.72M
sharesOutstanding 3.65M
sharesShort 4.88K
sharesShortPriorMonth 4.83K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.11%
Short Ratio help_outline 0.32%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -1.957
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -7.62M
trailingEps -2.35%
forwardEps -2.55%
enterpriseToEbitda -2.11
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.99 3Q 2023
institutionsCount 13
lastUpdated Nov. 9, 2023, 6:30 p.m.